Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals    REGN

REGENERON PHARMACEUTICALS

(REGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on REGENERON PHARMACEUTICALS
02/05/21 FY 2020 Earnings Release
02/05/21 | 08:30am FY 2020 Earnings Call
05/06/21 Q1 2021 Earnings Release (Projected)
08/05/21 Interim 2021 Earnings Release (Projected)
Past events on REGENERON PHARMACEUTICALS
01/11/21 | 08:20am JP Morgan Healthcare Conference
12/07/20 | 04:30pm American Society of Hematology Meeting
12/02/20 | 08:00am Piper Sandler Health Care Conference
12/01/20 | 10:30am Evercore ISI HealthCONx Conference
Upcoming sector events for REGENERON PHARMACEUTICALS
01/27/21 GALAPAGOS NV : Degroof Petercam Healthcare Conference
01/27/21 LONZA GROUP LTD : FY 2020 Earnings Release
01/27/21 | 08:30am LONZA GROUP LTD : FY 2020 Earnings Call
01/31/21 TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
More events
Past sector events for REGENERON PHARMACEUTICALS
01/21/21 | 10:30pm BIOCON LIMITED : Q3 2021 Earnings Call
01/21/21 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
01/21/21 BIOCON LIMITED : Q3 2021 Earnings Release
01/20/21 | 01:00pm IOVANCE BIOTHERAPEUTICS, INC. : B. Riley Oncology Investor Conference
Annual publications
Annual results201520162017201820192020 (e)
Sales
M $
Released
Forecast
Spread
4 104
4 177
-1,8%
4 860
4 923
-1,3%
5 872
5 788
1,5%
6 711
6 520
2,9%
7 863
7 816
0,61%

8 494
Operating income
(EBITDA)
M $
Released
Forecast
Spread
1 327
1 501
-12%
1 435
1 470
-2,3%
2 732
2 658
2,8%
3 110
2 959
5,1%
3 420
3 610
-5,3%

4 158
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 252
1 392
-10%
1 331
1 351
-1,5%
2 080
2 094
-0,70%
2 534
2 424
4,5%
2 210
2 285
-3,3%

3 483
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
1 225
1 369
-11%
1 330
1 357
-2,0%
2 079
2 075
0,16%
2 554
2 543
0,39%
2 429
2 308
5,3%

3 586
Net income
M $
Released
Forecast
Spread
636
680
-6,5%
896
894
0,12%
1 199
1 438
-17%
2 444
2 257
8,3%
2 116
1 998
5,9%

3 172
EPS
$
Released
Forecast
Spread
5,52
5,95
-7,2%
7,70
7,66
0,51%
10,3
12,6
-18%
21,3
19,7
7,9%
18,5
17,6
4,7%

28,0
Announcement Date02/09/201602/09/201702/08/201802/06/201902/06/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
2 048
1 982
3,4%
2 170
2 101
3,2%
1 828
1 811
0,96%
1 952
1 746
12%
2 294
2 085
10%

2 405
Operating income
(EBITDA)
M $
Released
Forecast
Spread
909
888
2,4%
989
933
5,9%
756
867
-13%
715
890
-20%
1 112
907
23%

1 194
Operating profit
(EBIT)
M $
Released
Forecast
Spread
739
757
-2,4%
676
781
-13%
700
747
-6,3%
656
714
-8,1%
1 053
850
24%

1 027
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
769
730
5,2%
890
795
12%
669
770
-13%
919
707
30%
998
861
16%

885
Net income
M $
Released
Forecast
Spread
670
643
4,1%
792
682
16%
625
630
-0,93%
897
596
51%
842
713
18%

799
EPS
$
Released
Forecast
Spread
5,86
5,69
2,9%
6,93
6,18
12%
5,43
5,50
-1,3%
7,61
5,07
50%
7,39
6,35
16%

7,10
Announcement Date11/05/201902/06/202005/05/202008/05/202011/05/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise